pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 545 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
rexlemestrocel-L
Revascor (rexlemestrocel-L)
Hypoplastic Left Heart Syndrome
$MESOMESOBLAST LTD
0 catalysts
Phase 3
ribupatide
ribupatide [INN]
Obesity
$KLRAKailera Therapeutics, Inc.
0 catalysts
Phase 3
riliprubart
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
$SNYSanofi
0 catalysts
← prev
page 16 of 19
next →
131
Pain89
Neurology1
Phase 3
rilparencel
Chronic Kidney Disease (Chronic Renal Failure)
$PROKPROKIDNEY CORP.
0 catalysts
Phase 3
rinatabart sesutecan
Epithelial Ovarian Cancer
Genmab AS
0 catalysts
Phase 3
rinvecalinase alfa
Acute Ischemic Stroke
$DMACDiaMedica Therapeutics Inc.
0 catalysts
Phase 3
ripasudil hydrochloride
Fuchs Endothelial Corneal Dystrophy (FECD)
Rho-associated protein kinase
Kowa Co Ltd
0 catalysts
Phase 3
rivunatpagene miziparvovec
Wilson Disease
$RAREUltragenyx Pharmaceutical Inc.
0 catalysts
Phase 3
romiplostim
Nplate (romiplostim)
Thrombocytopenia
Thrombopoietin receptor
$AMGNAMGEN INC
0 catalysts
Phase 3
romosozumab
Evenity (romosozumab-aqqg)
Osteogenesis Imperfecta
Sclerostin
$AMGNAMGEN INC
0 catalysts
Phase 3
rostaporfin
Metastatic Breast Cancer
TuHURA Biosciences Inc
0 catalysts
Phase 3
sacituzumab tirumotecan
Adenocarcinoma Of The Gastroesophageal Junction
$MRKMerck & Co., Inc.
0 catalysts
Phase 3
safusidenib
safusidenib [INN]
Malignant Glioma
$NUVBNuvation Bio Inc.
0 catalysts
Phase 3
salanersen
Spinal Muscular Atrophy (SMA)
$BIIBBIOGEN INC.
0 catalysts
Phase 3
sargramostim
Leukine (sargramostim)
Metastatic Melanoma
Granulocyte-macrophage colony-stimulating factor receptor
Partner Therapeutics Inc
0 catalysts
Phase 3
saroglitazar magnesium
Lipaglyn (saroglitazar magnesium)
Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Zydus Therapeutics Inc
0 catalysts
Phase 3
satralizumab
Enspryng (satralizumab-mwge)
Demyelinating Diseases
IL6Ralpha/GP130
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 3
sefaxersen sodium
IgA Nephropathy (Berger's Disease)
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 3
selatogrel
selatogrel [INN]
Myocardial Infarction
Idorsia Pharmaceutical Ltd
0 catalysts
Phase 3
selenium sulfide
Selenium Sulfide (selenium sulfide [USP])
Meibomian Blepharitis
Azura Ophthalmics Pty Ltd
0 catalysts
Phase 3
seltorexant
Insomnia
Orexin receptor type 2
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 3
seralutinib
Pulmonary Arterial Hypertension
Platelet-derived growth factor receptorMacrophage colony-stimulating factor 1 receptor
$GOSSGossamer Bio, Inc.
0 catalysts
Phase 3
setrusumab
Osteogenesis Imperfecta
Sclerostin
$RAREUltragenyx Pharmaceutical Inc.
0 catalysts
Phase 3
sevasemten
Becker Muscular Dystrophy
$EWTXEdgewise Therapeutics, Inc.
0 catalysts
Phase 3
simoladagene autotemcel
Adenosine Deaminase (ADA) Deficiency Related SCID
Rarity PBC
0 catalysts
Phase 3
sitravatinib malate
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
0 catalysts
Phase 3
sodium benzoate
NaBen (sodium benzoate)
Schizophrenia
SyneuRx International (Taiwan) Corp
0 catalysts
Phase 3
sodium iodide
sodium iodide [USP]
Myocardial Infarction
Faraday Pharmaceuticals Inc
0 catalysts
Phase 3
sofetabart mipitecan
Fallopian Tube Cancer
Eli Lilly and Co
0 catalysts
Phase 3
sonelokimab
Psoriatic Arthritis
Interleukin-17AInterleukin-17F
$MLTXMoonLake Immunotherapeutics
0 catalysts